Current Management of CINV

Chemotherapy-induced nausea and vomiting (CINV) prevention is important to reduce overall morbidity financial burden in patients receiving chemotherapy. Severe symptoms the patient's quality of life can interfere with further treatment. The five major forms CINV (ie, acute, delayed, predicted, breakthrough, refractory) often include 5-HT3 receptor antagonists, NK1 various treatments that corticosteroids. Despite significant research development efforts on antiemetics, treatment remains a challenge, waiting for many needs be adequately addressed, including those are vulnerable despite treated. This review hope raise awareness discuss current management.